KIYATEC, Inc., a Clemson-based company, was selected to participate in The University Innovation and Entrepreneurship Showcase that took place on Capitol Hill on April 10. The event, hosted by the Association of Public and Land-grant Universities (APLU) and the Association of American Universities (AAU), recognizes the impact that federally-funded research has on driving entrepreneurship and innovation.
KIYATEC’S innovative research on 3D cell culture began at Clemson University. Their ex vivo 3D cell culture technology allows accurate modeling and prediction of cancer patient response to drug therapies. KIYATEC’S validated process uses cancer cells taken from patients via surgical or biopsy tissues to create a life-like replication in order to determine what treatments the patient will respond to prior to beginning the treatment.
Startups for the showcase were chosen based on the level of student engagement in the startup, the strength of the technology the startup produces, and its relationship to research. For more information on KIYATEC, click here.
